Development Pipeline

 DiscoveryPreclinicalPhase 1Phase 2Phase 3
 Discovery Preclinical Phase 1 Phase 2 Phase 3
Achillion Compounds      
PNH (oral)Complement Factor D Inhibitors  
  
    
aHUS (oral)Complement Factor D Inhibitor  
  
    
Dry AMDComplement Factor D Inhibitor  
  
    
Other complement diseases 
  
    

HCV: Janssen Collaboration      
odalasvir (ACH-3102)NS5A Inhibitor    
  
    
ACH-3422Nucleotide NS5B Polymerase Inhibitor   
  
    
SovaprevirNS3/4A Protease Inhibitor    
  
    

About Achillion

At Achillion, we are committed to applying our expertise of biology and structure-guided design and a deep understanding of patient and clinical needs to develop innovative treatment solutions aimed at improving patients' lives. More...

Research Realized

About our innovative research

Harnessing innovation to discover novel therapies is our passion. Click to learn more about our research.

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue